Search Results - "Wall, Luke A"

Refine Results
  1. 1

    Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach by Wall, Luke A, Wisner, Elizabeth L, Gipson, Kevin S, Sorensen, Ricardo U

    Published in Frontiers in immunology (31-03-2020)
    “…Bronchiectasis, the presence of bronchial wall thickening with airway dilatation, is a particularly challenging complication of primary antibody deficiencies…”
    Get full text
    Journal Article
  2. 2

    Development of IgE-mediated food allergies in children with history of food protein-induced allergic proctocolitis: a series of five cases by Tran, Kim L, Wisner, Elizabeth L, Jeha, George M, Wall, Luke A

    Published in Frontiers in allergy (28-03-2024)
    “…Food protein-induced allergic proctocolitis (FPIAP) is a non-IgE-mediated allergic condition that presents with hematochezia in otherwise healthy infants. It…”
    Get full text
    Journal Article
  3. 3

    Specific Antibody Deficiencies by Wall, Luke A., MD, Dimitriades, Victoria R., MD, Sorensen, Ricardo U., MD

    “…Patients with specific antibody deficiency (SAD) have a deficient immunologic response to polysaccharide antigens. Such patients experience sinopulmonary…”
    Get full text
    Journal Article
  4. 4

    Phenotypic Variability of C1q Deficient Patients by Kamireddy, Samata, MD, Wisner, Elizabeth L., MD, Wall, Luke A., MD

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Case B is a 3-year-old male with developmental delay and history of recurrent otitis media, viral respiratory and gastrointestinal infections, and shingles…”
    Get full text
    Journal Article
  5. 5

    Immunodeficiency Associated with FOXP1 (3p13) Deletion by Netterville, Adrianne C., MD, Wall, Luke A., MD

    Published in Journal of allergy and clinical immunology (01-02-2015)
    “…While murine models have demonstrated that FOXP1 is an essential regulator of macrophage, B and T cell development, reports describing the immunologic…”
    Get full text
    Journal Article
  6. 6

    Harnessing Pharmacogenomics to Guide the Treatment of LRBA Deficiency by Wisner, Elizabeth L., MD, Korah-Sedgwick, Michelle, MD, Wall, Luke A., MD, Bleesing, Jack J., MD, PhD, Dimitriades, Victoria, MD

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Immunologic work-up now revealed low IgG (355 mg/dl), low IgA (<7.8 mg/dl), normal IgM, non-protective pneumococcal titers, low CD8 T cells (390/mcL), and low…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Suspected Reaction With Cephalosporin May Be a Predictive Factor for β-Lactam Allergy in Children by Wall, Luke A.

    Published in Pediatrics (Evanston) (01-12-2019)
    “…Purpose of the Study: To determine the frequency and risk factors of confirmed allergy in patients who report β-lactam allergy and evaluate cross-reactivity…”
    Get full text
    Journal Article
  9. 9

    Inherited p40phox Deficiency Differs From Classic Chronic Granulomatous Disease by Wall, Luke A.

    Published in Pediatrics (Evanston) (01-12-2019)
    “…Purpose Of the Study: To characterize clinical and laboratory aspects of p40phox deficiency, a unique autosomal recessive form of chronic granulomatous disease…”
    Get full text
    Journal Article
  10. 10

    Early Introduction of Egg and the Development of Egg Allergy in Children: A Systematic Review and Meta-analysis by Wall, Luke A.

    Published in Pediatrics (Evanston) (01-12-2019)
    “…Purpose of the Study: To systematically review the existing literature regarding the effect of early introduction of egg on the development of egg allergy…”
    Get full text
    Journal Article
  11. 11

    The Treatment of Primary Immune Deficiencies: Lessons Learned and Future Opportunities by Paris, Kenneth, Wall, Luke A.

    Published in Clinical reviews in allergy & immunology (01-08-2023)
    “…Primary immunodeficiency is a group of disorders associated with susceptibility to infectious agents and the development of various comorbidities. Many primary…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab by Korah-Sedgwick, Michelle M., Wall, Luke A.

    Published in Case reports in immunology (01-01-2018)
    “…Patients with X-linked lymphoproliferative disease 1 (XLP1) are exquisitely susceptible to Epstein-Barr virus (EBV), with the first EBV infection often…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20